Tech Company Financing Transactions
Cumulus Neuroscience Funding Round
Cumulus Neuroscience, based in Belfast, raised $4.4 million from WhiteRock Capital Partners, ACF Investors and Co-FundNI.
Transaction Overview
Company Name
Announced On
7/8/2025
Transaction Type
Venture Equity
Amount
$4,400,000
Round
Undisclosed
Investors
WhiteRock Capital Partners (Lead Investor) (David McCurley)
Proceeds Purpose
The funding will be used to invest in marketing and further scale the hiring of key personnel, including a Head of B2B Marketing and Sales Operations and a Vice President of Business Development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Concourse Building 3 Queens Rd
Belfast, BT3 9DT
UK
Belfast, BT3 9DT
UK
Phone
Website
Email Address
Overview
We're developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. We have developed the world's most advanced, at-home, medical grade, flexible data collection and analytics platform to solve some of the biggest challenges in monitoring functional brain health and brain disorders. Brain disorders are a growing global challenge, but drug discovery and management of these CNS diseases are hampered by late diagnosis, poor stratification and difficulty in monitoring patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tina Sampath
Browse more venture capital transactions:
Prev: 7/8/2025: LumenStream venture capital transaction
Next: 7/8/2025: Flexi Software venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document all VC transactions involving tech companies. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs